Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy.
-
Published:1992-09-01
Issue:5
Volume:72
Page:361-364
-
ISSN:1651-2057
-
Container-title:Acta Dermato-Venereologica
-
language:
-
Short-container-title:Acta Derm Venereol
Author:
Themido R,Loureiro M,Pecegueiro M,Brandão M,Campos M C
Abstract
Eighty-four patients with severe psoriasis who required methotrexate (MTX) therapy have been reviewed. A total of 134 liver biopsies were performed. The lack of correlation between alcohol intake and the use of potential hepatotoxic drugs with pretreatment liver biopsies is noted. A review of 30 patients who had liver biopsies performed before and after MTX treatment showed no statistically significant difference between the histological grades before and after treatment. Nor was there any absolute correlation between the cumulative MTX doses and the histological changes of follow-up biopsies. In this group of patients, 15 (50%) developed fibrosis, which was severe in 2 patients, after 3,431 mg MTX average dose. Cirrhosis was observed in 3 patients (10%) after 1,667 mg MTX average dose. Follow-up liver biopsies are recommended for patients treated with MTX.
Publisher
Medical Journals Sweden AB
Subject
Dermatology,General Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献